相似文献
1
Unraveling the PAF-AH/Lp-PLA2 controversy.
J Lipid Res. 2014 Sep;55(9):1811-4. doi: 10.1194/jlr.E052886. Epub 2014 Jul 9.
2
Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults.
Lipids Health Dis. 2009 Jun 5;8:19. doi: 10.1186/1476-511X-8-19.
3
The effect of lipoprotein-associated phospholipase A2 deficiency on pulmonary allergic responses in Aspergillus fumigatus sensitized mice.
Respir Res. 2012 Nov 12;13(1):100. doi: 10.1186/1465-9921-13-100.
4
Platelet-activating factor-acetylhydrolase can monodeacylate and inactivate lipoteichoic acid.
Clin Vaccine Immunol. 2006 Apr;13(4):452-8. doi: 10.1128/CVI.13.4.452-458.2006.
5
Novel enzymatic method for assaying Lp-PLA in serum.
Clin Chim Acta. 2018 Jun;481:184-188. doi: 10.1016/j.cca.2018.03.012. Epub 2018 Mar 15.
6
[Meta-analysis for the relationship between lipoprotein-associated phospholipase A2 and ischemic stroke].
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017 Feb 28;42(2):208-214. doi: 10.11817/j.issn.1672-7347.2017.02.015.
7
Platelet activating factor levels and metabolism in Tangier disease: a case study.
Lipids Health Dis. 2012 Jul 8;11:89. doi: 10.1186/1476-511X-11-89.
8
Leishmania parasites possess a platelet-activating factor acetylhydrolase important for virulence.
Mol Biochem Parasitol. 2012 Nov;186(1):11-20. doi: 10.1016/j.molbiopara.2012.08.005. Epub 2012 Aug 28.
9
Extracellular phospholipases in atherosclerosis.
Biochimie. 2010 Jun;92(6):594-600. doi: 10.1016/j.biochi.2010.02.002. Epub 2010 Feb 12.
10
Lipoprotein-associated phospholipase A2: how effective as a risk marker of cardiovascular disease and as a therapeutic target?
Inflamm Allergy Drug Targets. 2011 Aug;10(4):236-46. doi: 10.2174/187152811796117771.
引用本文的文献
1
Phospholipase PLA2G7 is complementary to GPX4 in mitigating punicic-acid-induced ferroptosis in prostate cancer cells.
iScience. 2024 Apr 18;27(5):109774. doi: 10.1016/j.isci.2024.109774. eCollection 2024 May 17.
2
Can Electronegative LDL Act as a Multienzymatic Complex?
Int J Mol Sci. 2023 Apr 11;24(8):7074. doi: 10.3390/ijms24087074.
3
A proteomic approach for investigating the pleiotropic effects of statins in the atherosclerosis risk in communities (ARIC) study.
J Proteomics. 2023 Feb 10;272:104788. doi: 10.1016/j.jprot.2022.104788. Epub 2022 Dec 5.
4
Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy.
J Cachexia Sarcopenia Muscle. 2021 Oct;12(5):1333-1351. doi: 10.1002/jcsm.12758. Epub 2021 Aug 23.
5
Metabolic Dysregulation of the Lysophospholipid/Autotaxin Axis in the Chromosome 9p21 Gene SNP rs10757274.
Circ Genom Precis Med. 2020 Jun;13(3):e002806. doi: 10.1161/CIRCGEN.119.002806. Epub 2020 May 12.
6
Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives.
Molecules. 2019 Dec 3;24(23):4414. doi: 10.3390/molecules24234414.
7
SERUM LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN MALES WITH METABOLIC SYNDROME AND OBSTRUCTIVE SLEEP APNEA.
Acta Endocrinol (Buchar). 2018 Jan-Mar;14(1):36-42. doi: 10.4183/aeb.2018.36.
8
Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF.
J Lipid Res. 2018 Nov;59(11):2063-2074. doi: 10.1194/jlr.M085704. Epub 2018 Aug 23.
9
Inflammation, not Cholesterol, Is a Cause of Chronic Disease.
Nutrients. 2018 May 12;10(5):604. doi: 10.3390/nu10050604.
10
Phospholipid signaling in innate immune cells.
J Clin Invest. 2018 Jul 2;128(7):2670-2679. doi: 10.1172/JCI97944. Epub 2018 Apr 23.
本文引用的文献
1
GSK's darapladib failures dim hopes for anti-inflammatory heart drugs.
Nat Rev Drug Discov. 2014 Jul;13(7):481-2. doi: 10.1038/nrd4381.
2
To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase.
J Lipid Res. 2014 Sep;55(9):1847-54. doi: 10.1194/jlr.R045492. Epub 2014 May 23.
3
Darapladib for preventing ischemic events in stable coronary heart disease.
N Engl J Med. 2014 May 1;370(18):1702-11. doi: 10.1056/NEJMoa1315878. Epub 2014 Mar 30.
4
Generation of membrane diversity by lysophospholipid acyltransferases.
J Biochem. 2013 Jul;154(1):21-8. doi: 10.1093/jb/mvt048. Epub 2013 May 21.
5
Effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity in Japanese dyslipidemic patients, with exploratory analysis of a PLA2G7 gene polymorphism of Val279Phe.
Circ J. 2013;77(6):1518-25. doi: 10.1253/circj.cj-12-0813. Epub 2013 Feb 23.
6
Amelioration of atherosclerosis in apolipoprotein E-deficient mice by inhibition of lipoprotein-associated phospholipase A2.
Clin Invest Med. 2013 Feb 1;36(1):E32-41. doi: 10.25011/cim.v36i1.19403.
7
Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients.
PLoS One. 2012;7(10):e48171. doi: 10.1371/journal.pone.0048171. Epub 2012 Oct 31.
8
Darapladib effect on circulating high sensitive troponin in patients with acute coronary syndromes.
Atherosclerosis. 2012 Nov;225(1):142-7. doi: 10.1016/j.atherosclerosis.2012.06.064. Epub 2012 Aug 5.
9
Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2.
J Lipid Res. 2012 Sep;53(9):1767-82. doi: 10.1194/jlr.R024190. Epub 2012 Jun 4.
10
Relationship of lipoprotein-associated phospholipase A₂ mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial.
Clin Chem. 2012 May;58(5):877-86. doi: 10.1373/clinchem.2011.180281. Epub 2012 Mar 14.
Zotero 插件